most effective glp-1 for obesity treatment 2025 Q&A: Long-term success of therapies hinges on more than just a prescription GLP-1 receptor agonists show anti-cancer

Ginsenoside compound K increases glucagon-like peptide-1 release and L-cell abundance in db/db mice through TGR5/YAP signaling

What the FDA prescribing labels actually say Let us start with what the regulatory authorities have on record

The GLP-1 program should be stored at the appropriate temperature to maintain its quality

Discussion Case #1 demonstrates the potential role that GLP-1 RAs can play in helping IIH patients optimize their weight and, therefore, mitigate their risk of vision loss

You feel full faster and crave food less

Razia Hashmi, chief medical officer at the Blue Cross Blue Shield Association, put it bluntly: "The current insurance construct was not designed to handle this kind of demand." She was right